Hepatitis B testing and treatment rates are low among US veterans
Daclatasvir TRIO regimen has good cure rates for hepatitis C patients with or without cirrhosis
Young drug injectors on opioid maintenance therapy have lower risk of hepatitis C infection
Sustained virological response to hepatitis C treatment reduces mortality, liver cancer and liver transplants
Sofosbuvir/ledipasvir cures nearly all genotype 1 HCV for people with HIV co-infection
